Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,849,684 papers from all fields of science
Search
Sign In
Create Free Account
NCR2 wt Allele
Known as:
NK-p44
, Lymphocyte Antigen 95, Mouse, Homolog of Gene
, Natural Cytotoxicity Triggering Receptor 2 wt Allele
Expand
Human NCR2 wild-type allele is located in the vicinity of 6p21.1 and is approximately 15 kb in length. This allele, which encodes natural…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
6 relations
6p21.1
Ligand Binding
NCR2 protein, human
NK Cell Activation
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Innate Lymphoid Cells Have Decreased HLA-DR Expression but Retain Their Responsiveness to TLR Ligands during Sepsis
D. Cruz-Zárate
,
G. L. Cabrera-Rivera
,
+10 authors
I. Wong-Baeza
Journal of Immunology
2018
Corpus ID: 207435946
Sepsis, one of the leading causes of death in intensive care units, is caused by a dysregulated host response to infection that…
Expand
2016
2016
Identification of the gC1qR sites for the HIV-1 viral envelope protein gp41 and the HCV core protein: Implications in viral-specific pathogenesis and therapy.
L. Pednekar
,
Alisa Valentino
,
+9 authors
B. Ghebrehiwet
Molecular Immunology
2016
Corpus ID: 21478459
2014
2014
Ex vivo-expanded natural killer cells kill cancer cells more effectively than ex vivo-expanded γδ T cells or αβ T cells.
Xuewen Deng
,
H. Terunuma
,
A. Terunuma
,
Tsubasa Takane
,
M. Nieda
International Immunopharmacology
2014
Corpus ID: 39948590
Review
2012
Review
2012
Human NK cell recognition of target cells in the prism of natural cytotoxicity receptors and their ligands
M. Brusilovsky
,
B. Rosental
,
A. Shemesh
,
M. Appel
,
A. Porgador
Journal of Immunotoxicology
2012
Corpus ID: 37647526
The matter of the pathogen- and cancer-associated ligands recognized by the Natural Cytotoxicity Receptors (NCRs) has been a…
Expand
2012
2012
Natural killer cell recognition and killing of activated hepatic stellate cells
J. Clària
Gut
2012
Corpus ID: 206956697
Liver fibrosis is a major cause of morbidity and mortality worldwide as a result of chronic liver injury. Liver fibrosis is a…
Expand
2010
2010
Differences in natural killer cell quantification and receptor profile expression in HIV-1 infected Chinese children.
G. Fu
,
Xu Chen
,
+10 authors
Yayi Hou
Cellular Immunology
2010
Corpus ID: 29893269
Highly Cited
2007
Highly Cited
2007
Expression Analysis of the Ligands for the Natural Killer Cell Receptors NKp30 and NKp44
A. Byrd
,
S. Hoffmann
,
M. Jarahian
,
F. Momburg
,
C. Watzl
PLoS ONE
2007
Corpus ID: 9640579
Background The natural cytotoxicity receptors (NCR) are important to stimulate the activity of Natural Killer (NK) cells against…
Expand
2006
2006
Activated gammadelta T cells express the natural cytotoxicity receptor natural killer p 44 and show cytotoxic activity against myeloma cells.
M. von Lilienfeld-Toal
,
J. Nattermann
,
+4 authors
I. Schmidt-Wolf
Clinical and Experimental Immunology
2006
Corpus ID: 38550900
gammadelta T cells account for up to 10% of T lymphocytes in the peripheral blood of healthy donors. They can be activated by…
Expand
Highly Cited
2000
Highly Cited
2000
The CMRF-35H gene structure predicts for an independently expressed member of an ITIM/ITAM pair of molecules localized to human chromosome 17.
G. Clark
,
B. Green
,
D. Hart
Tissue Antigens
2000
Corpus ID: 39969725
The CMRF-35 monoclonal antibody recognizes an epitope found on at least two cell surface molecules, differentially expressed by…
Expand
Highly Cited
2000
Highly Cited
2000
Triggering receptors involved in natural killer cell-mediated cytotoxicity against choriocarcinoma cell lines.
S. Sivori
,
S. Parolini
,
E. Marcenaro
,
R. Millo
,
C. Bottino
,
A. Moretta
Human Immunology
2000
Corpus ID: 30114147
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE